BIO Applauds EPA’s Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel Standard
Heliae plant will mass-produce algae for multiple uses Continue reading
Jil Tardiff, who recently joined the UA College of Medicine and the BIO5 Institute, holds the Steven M. Gootter Endowed Chair for the Prevention and Treatment of Sudden Cardiac Death at the UA Sarver Heart Center. Continue reading
Get the latest AZBio Expo Coverage from the Phoenix Business JournalContinue reading
A key requriement for our bioscience community to keep movng forward faster is the approval of the 2012 PDUFA agreements. Something fishy could hold things up and AZBio shares the G2 on why this is not a good idea. Continue reading
Infectious diseases – both old and new – continue to exact a devastating toll, causing some 13 million fatalities per year around the world.
Vaccines remain the best line of defense against deadly pathogens, and now Kathryn Sykes and Stephen Johnston, researchers at ASU’s Biodesign Institute, along with co-author Michael McGuire from the University of Texas Southwestern Medical Center, are using clever functional screening methods to attempt to speed new vaccines into production that are both safer and more potent.Continue reading
The Biotechnology Industry Organization (BIO) is actively engaging with Congress to support industrial biotechnology efforts across the country as things heat up on The Hill. Continue reading
A memo to Arizona’s Bioscience Industry Members with details on the recently announced Bioeconomy BlueprintContinue reading
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry – one acutely sensitive to changes in the body that may be harbingers of illness.Continue reading
Today, the Obama Administration announced its commitment to strengthening bioscience research as a major driver of American innovation and economic growth. The National Bioeconomy Blueprint outlines steps that agencies will take to drive the bioeconomy—economic activity powered by research and innovation in the biosciences—and details ongoing efforts across the Federal government to realize this goal.Continue reading